Project title: MIGRAINE DIAGNOSTIC AND TREATMENT
Company name : BIOPHYSICAL MIND TECHNOLOGIES LTD.
TECHNOLOGIES LTD.
TECHNOLOGICAL FIELD
Medical Equipment
KEY WORDS
Migraine Diagnostic,
Migraine Treatment, CES
PROJECT SUMMARY
The Company has developed Cranial Electro stimulation (CES)
Technology for the diagnosis and treatment of an array of
debilitating neurological disorders. The first indication to be
addressed by BMT is the accurate diagnosis and effective
treatment of severe migraines.
BMT is working on the development of two products for its severe
migraine indication. The first, the "CES system" is intended for
use by migraine patients in pain clinics, hospitals' neurology
departments, and private neurology clinics. The second, the "CES
Personal Device" is intended for home-use, and will initially be
offered through pain clinics. At later stages, the CES personal
device will be offered through over-the-counter sales in
pharmacies, enabling easier access for the mass market of
migraine patients. Treatment protocols will be administered and
monitored by neurologists in the above mentioned various
facilities.
ENTREPRENEURS
Dr. Y. Naisberg - MD, well
experienced in psychiatry and neurology
Prof. A. Weizman - MD, Felenstein
Research Center, Rabin Campus Beilinson Medical Center, Suckler
Faculty of Medicine. Tel Aviv.
Dr. A. Grinshpoon - MD, Psychiatric
Division, Ministry of Health
Mr. Eitan Orlin - CEO
PROJECT STATUS
The Company started its incubator period since 11/2004.
The company produced 3 prototypes of the device using it in "Bnei
Zion" hospital in Haifa and some more clinics for trials.
- 33 migraine suffers made a diagnosis and 50% got a treatment.
- The treatment results point that the migraine suffers feel
better after about 7 treatments
- The treatment results point also that there are a significant
positive correlations between some pairs of electrodes then
others.
-The results point of a pattern of intensity of the pain becomes
more moderate for the experiment group, when in the last few
measurements the initial pattern is reversed, as the subjects in
the control group report stronger intensities of pain than
reported at the beginning of the experiment, and also stronger
migraine intensities in comparison to the experiment group.
COOPERATION REQUIRED
Looking for new strategic partners.
---------------------------------------------
TEL: 972-52-2615380; FAX: +972-4-8493498 E-MAIL:
bmt_ltd@netvision.net.il
Request for more information, about this project.
Note - you have to be registered in this server to
request information. If you haven't done so
yet, please:
Register in this server
and your requests will be forwarded to the developer, who
will contact you directly
List of projects that you already requested more information about